Use of liposome-associated bupivacaine in a cancer pain syndrome

Anaesthesia

Volumn 51, Issue 6, 1996, Pages 578-579

  Lafont, N D ^a   Legros, F J ^a   Boogaerts, J G ^b  

^a FREE UNIVERSITY OF BRUSSELS   (Belgium)

^b City Hospital   (Belgium)

Author keywords

Anaesthetic techniques regional; epidural; Anaesthetics, local; bupivacaine; Liposome; drug association

Indexed keywords

BUPIVACAINE; LIPOSOME; LOCAL ANESTHETIC AGENT;

AGED; ARTICLE; CANCER PAIN; CASE REPORT; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; DRUG EFFICACY; ENCAPSULATION; EPIDURAL ANESTHESIA; HUMAN; INTRATHECAL DRUG ADMINISTRATION; LUNG CANCER;

AGED; ANALGESIA, EPIDURAL; ANESTHETICS, LOCAL; BUPIVACAINE; DRUG CARRIERS; HUMANS; LIPOSOMES; LUNG NEOPLASMS; PAIN, INTRACTABLE; SYNDROME;

EID: 0029991599     PISSN: 00032409     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2044.1996.tb12569.x     Document Type: Article

References (18)

1. MATHER LE, COUSINS MJ. Local anesthetics and their current clinical use. Drugs 1979; 18: 185-208.
2. COVINO BG. Clinical pharmacology of local anesthetic agents. In: COUSINS MJ, BRIDENBAUGH PO, eds. Neural blockade in clinical anesthesia and management of pain. 2nd edn. Philadelphia: J. B. Lippincott Company. 1988: 111-44.
3. MOORE DC, BALFOUR RI, FITZGIBBONS D. Convulsive arterial plasma levels of bupivacaine and response to diazepam therapy. Anesthesiology 1979; 50: 454-6.
4. DE JONG RH, DEROSA RA, BONIN JD, JAMBLE CA. Cerebral and circulatory effects of high-dose bupivacaine and etidocaine. Anesthesiology 1980; 53: S224.
5. MOORE DC, THOMPSON GE, CRAWFORD RD. Long acting local anesthetic drugs and convusions in humans. Anesthesiology 1982; 56: 230-2.
6. SCOTT DB. Toxic effects of local anaesthetic agents on the central nervous system. British Journal of Anaesthesia 1986; 58: 732-5.
7. ALBRIGHT GA. Cardiac arrest following regional anesthesia with etidocaine or bupivacaine. Anesthesiology 1979; 51: 285-7.
8. REIZ S, NATH S, Cardiotoxicity of local anaesthetic agents. British Journal of Anaesthesia 1986; 58: 736-46.
9. BOBA A. Bupivacaine-induced cardiac arrest. Anesthesia and Analgesia 1990; 70: 459-69.
10. TUCKER GT. Safety in numbers. The role of pharmacokinetics in local anesthetic toxicity: the 1993 ASRA lecture. Regional Anesthesia 1994; 19: 155-63.
11. LEGROS FJ, Luo H, BOURGEOIS P, LAFONT ND, BOOGAERTS JG. Influence of different liposomal formulations on the pharmacokineties of encapsulated bupivacaine. Anesthesiology 1990; 73: A851.
12. BTOGAERTS JG, LAFONT ND. LUO H. LEGROS FJ. Plasma concentrations of bupivacaine after brachial plexus administration of liposome-associated and plain solutions to rabbits. Canadian Journal of Anaesthesia 1993; 40: 1201-4.
13. LEGROS FJ, LAFONT ND, DONNAY M, BOOGAERTS JG. Motor blockade and absence of local nerve toxicity induced by liposomal bupivacaine injected into the axillary brachial plexus of rabbits. Acta Anaesthesiologica Belgica 1995; 46: 19-24.
14. BOOGAERTS JG, DECLERCQ A, LAFONT ND, BENAMEUR H, AKODAD EM, LEGROS FJ. Toxicity of bupivacaine encapsulated in liposomes and injected intravenously. Comparison with plain solutions. Anesthesia and Analgesia 1993; 76: 553-5.
15. LAFONT ND, BOOGAERTS JG, LEGROS FJ. Use of liposome-associated bupivacaine for the management of a chronic pain syndrome. Anesthesia and Analgesia 1994; 73: 818.
16. BOOGAERTS JG, LAFONT ND, DECLERQ A. LUO H, GRAVET E, BIANCHI J, LEGROS FJ. Epidural administration of liposomeassociated bupivacaine for the management of postsurgical pain. A first study. Journal of Clinical Anesthesia 1994; 6: 315-20.
17. LEGROS FJ, RUYSSCHAERT JM. Pharmaceutical composition containing a local anesthetic and/or centrally acting analgesic encapsulated in liposomes. U.S. Patent 5.244.678, 1993.
18. BOOGAERTS JG, LAEONT ND, CARLINO S, NOEL E, RAYNAL P, GOFFINET G. LEGROS FJ. Biodistribution of liposome-associated bupivacaine after extradural administration to rabbits. British Journal of Anaesthesia 1995; 75: 319-25.